Analysis Of The Effectiveness Of Total Neoadjuvant Therapy In The Treatment Of Patients With Rectal Cancer

Authors

  • Saydamatov X.U Assistant Professor of the Department of Oncology Andijan State Medical Institute Andijan, Uzbekistan

DOI:

https://doi.org/10.62480/tjms.2025.vol51.pp34-38

Keywords:

chemotherapy, reductions, treatment

Abstract

One of the major limitations of the traditional treatment sequence is that a substantial proportion of patients are unable to complete planned adjuvant chemotherapy. Postoperative complications, prolonged recovery, stoma-related issues, and decreased performance status frequently lead to dose reductions, treatment delays, or complete omission of systemic therapy.

Downloads

Published

2025-12-25

Issue

Vol. 51 (2025): TJMS

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

User Rights

Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).

Rights of Authors

Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.

How to Cite

Analysis Of The Effectiveness Of Total Neoadjuvant Therapy In The Treatment Of Patients With Rectal Cancer. (2025). Texas Journal of Medical Science, 51, 34-38. https://doi.org/10.62480/tjms.2025.vol51.pp34-38